British Association for Pyschopharmacology. To advance education and research in the science of psychopharmacology
The BAP was founded in 1974 with the general intention of bringing together those from academia, the health service and the pharmaceutical industry who are involved in the study of psychopharmacology. To this end the Association arranges scientific meetings, fosters research and teaching, encourages publication of results of research and provides guidance and information to the public on matters relevant to psychopharmacology, where appropriate.
The BAP has an extensive educational portfolio. The Certificate in Clinical Psychopharmacology provides up-to-date CPD and consists of three Core modules held each year – Anxiety Disorders, Schizophrenia and Affective Disorders – along with several optional modules on specialist topics.
The BAP launched the Pre-clinical Certificate in Psychopharmacology in July 2001. The aim of this Course is to increase awareness of, expertise and interest in, pre-clinical psychopharmacology through the provision of a series of training modules that cover key aspects of research on animals and humans as well as career development.
Twice yearly the BAP runs its three day Masterclasses in central London. These immensely popular courses update practicing healthcare professionals on current issues in psychopharmacology and are taught by leading UK psychopharmacologists.
Since 2011 the BAP has offered an Online CPD Resource, a regularly-updated resource presented by acknowledged experts and opinion leaders in their respective fields.
The BAP is one of the largest national psychopharmacology associations in the world.
Subscribe to the News Feed